A Translational Tool to Facilitate Use of Apolipoprotein B for Clinical Decision-Making.
Sign Up to like & getrecommendations! Published in 2022 at "Clinical chemistry"
DOI: 10.1093/clinchem/hvac161
Abstract: BACKGROUND Despite recent large-scale discordance studies showing definitively that atherosclerotic cardiovascular disease (ASCVD) risk correlates better with apolipoprotein B (apoB) than with low-density lipoprotein cholesterol (LDL-C), the latter remains the recommended metric for guiding lipid-lowering… read more here.
Keywords: translational tool; apob; facilitate use; ascvd risk ... See more keywords